drugset / Trial / NCT02693522
Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of recombinant human growth hormone on adult growth hormone deficiency
Timeline
- Start
- 2003-10
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eutropin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | — | Subcutaneous |